Aditxt (ADTX) Earnings Date & Reports

A.I. Advisor

published Earnings

ADTX is expected to report earnings to rise 4,058.27% to -11559 cents per share on August 30

Q2'23

Est.

$-115.60

Q1'23

Est.

$-2.78

Q4'22

Missed

by $0.48

Q3'22

Missed

by $1.38

Q2'22

Missed

by $253.50

The last earnings report on May 31 showed earnings per share of -277 cents, meeting the estimate of -277 cents. With 12.23M shares outstanding, the current market capitalization sits at 879.97K.

View a ticker or compare two or three

Compare

ADTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ADTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

737 North Fifth Street

Phone

+1 650 870-1200

Employees

Web

https://www.aditxt.com